Literature DB >> 11502253

Crossregulation between Neurogenin2 and pathways specifying neuronal identity in the spinal cord.

R Scardigli1, C Schuurmans, G Gradwohl, F Guillemot.   

Abstract

We have examined how genetic pathways that specify neuronal identity and regulate neurogenesis interface in the vertebrate neural tube. Here, we demonstrate that expression of the proneural gene Neurogenin2 (Ngn2) in the ventral spinal cord results from the modular activity of three enhancers active in distinct progenitor domains, suggesting that Ngn2 expression is controlled by dorsoventral patterning signals. Consistent with this hypothesis, Ngn2 enhancer activity is dependent on the function of Pax6, a homeodomain factor involved in specifying the identity of ventral spinal cord progenitors. Moreover, we show that Ngn2 is required for the correct expression of Pax6 and several homeodomain proteins expressed in defined neuronal populations. Thus, neuronal differentiation involves crossregulatory interactions between a bHLH-driven program of neurogenesis and genetic pathways specifying progenitor and neuronal identity in the spinal cord.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11502253     DOI: 10.1016/s0896-6273(01)00358-0

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  65 in total

Review 1.  Neurogenesis in embryos and in adult neural stem cells.

Authors:  Chris Kintner
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Divergent functions of the proneural genes Mash1 and Ngn2 in the specification of neuronal subtype identity.

Authors:  Carlos M Parras; Carol Schuurmans; Raffaella Scardigli; Jaesang Kim; David J Anderson; François Guillemot
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

3.  Genome-wide characterization of Foxa2 targets reveals upregulation of floor plate genes and repression of ventrolateral genes in midbrain dopaminergic progenitors.

Authors:  Emmanouil Metzakopian; Wei Lin; Mali Salmon-Divon; Heidi Dvinge; Elisabet Andersson; Johan Ericson; Thomas Perlmann; Jeffrey A Whitsett; Paul Bertone; Siew-Lan Ang
Journal:  Development       Date:  2012-06-13       Impact factor: 6.868

4.  Neurogenin 1 (Neurog1) expression in the ventral neural tube is mediated by a distinct enhancer and preferentially marks ventral interneuron lineages.

Authors:  Herson I Quiñones; Trisha K Savage; James Battiste; Jane E Johnson
Journal:  Dev Biol       Date:  2010-02-18       Impact factor: 3.582

5.  Nkx6 genes pattern the frog neural plate and Nkx6.1 is necessary for motoneuron axon projection.

Authors:  Darwin S Dichmann; Richard M Harland
Journal:  Dev Biol       Date:  2010-10-28       Impact factor: 3.582

6.  Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells.

Authors:  Soo-Kyung Lee; Bora Lee; Esmeralda C Ruiz; Samuel L Pfaff
Journal:  Genes Dev       Date:  2005-01-15       Impact factor: 11.361

7.  Sequential roles for Mash1 and Ngn2 in the generation of dorsal spinal cord interneurons.

Authors:  Amy W Helms; James Battiste; R Michael Henke; Yuji Nakada; Nicolas Simplicio; Francois Guillemot; Jane E Johnson
Journal:  Development       Date:  2005-05-18       Impact factor: 6.868

8.  Foxn4 acts synergistically with Mash1 to specify subtype identity of V2 interneurons in the spinal cord.

Authors:  Shengguo Li; Kamana Misra; Michael P Matise; Mengqing Xiang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

9.  Crystallization and preliminary X-ray analysis of the Pax6 paired domain bound to the Pax6 gene enhancer.

Authors:  Makoto Ito; Takuji Oyama; Kenji Okazaki; Kosuke Morikawa
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-10-25

Review 10.  How do genes regulate simple behaviours? Understanding how different neurons in the vertebrate spinal cord are genetically specified.

Authors:  Katharine E Lewis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-01-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.